Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Sharma East India Hospitals & Medical Research's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was -4.09%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
BOM:524548's 3-Year ROIIC % is ranked worse than 62.24% of 617
companies
in the Healthcare Providers & Services industry
Industry Median: 3.66
vs BOM:524548: -4.09
Sharma East India Hospitals & Medical Research (BOM:524548) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Sharma East India Hospitals & Medical Research 3-Year ROIIC % Related Terms
Sharma East India Hospitals & Medical Research 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sharma East India Hospitals & Medical Research 3-Year ROIIC % Chart
Sharma East India Hospitals & Medical Research Annual Data
BOM:524548 vs HCA, THC, EHC: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Sharma East India Hospitals & Medical Research's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sharma East India Hospitals & Medical Research 3-Year ROIIC % vs Healthcare Providers & Services Industry
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 15.246455 (Mar. 2026) - 19.1 (Mar. 2023) )
/
( 283.405 (Mar. 2026) - 189.144 (Mar. 2023) )
=
-3.853545
/
94.261
=
-4.09%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sharma East India Hospitals & Medical Research (BOM:524548) has a 3-Year ROIIC % of -4.09 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sharma East India Hospitals & Medical Research and its competitors. According to the industry distribution chart, Sharma East India Hospitals & Medical Research ranks #384 out of 617 companies in the Healthcare Providers & Services industry, placing it in the top 62.2%.
Is Sharma East India Hospitals & Medical Research's 3-Year ROIIC % too high?
Sharma East India Hospitals & Medical Research's current 3-Year ROIIC % is -4.09. Based on the distribution chart, Sharma East India Hospitals & Medical Research ranks #384 out of 617 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Sharma East India Hospitals & Medical Research has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sharma East India Hospitals & Medical Research's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sharma East India Hospitals & Medical Research ranks #384 out of 617 companies for 3-Year ROIIC %. This places Sharma East India Hospitals & Medical Research in the lower half of its industry. The industry median 3-Year ROIIC % is 3.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.66, based on 617 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sharma East India Hospitals & Medical Research and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sharma East India Hospitals & Medical Research's current 3-Year ROIIC % is -4.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sharma East India Hospitals & Medical Research stock overvalued right now?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research (BOM:524548) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹107.71, compared to a current price of ₹94.58 — trading 12.2% below its estimated fair value. The current 3-Year ROIIC % is -4.09. Sharma East India Hospitals & Medical Research's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Sharma East India Hospitals & Medical Research (BOM:524548), the current 3-Year ROIIC % is -4.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sharma East India Hospitals & Medical Research (BOM:524548) Overvalued in 2026?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research stock appears to be undervalued.
The current stock price of ₹94.58 is trading 12.2% below its estimated GF Value™ of ₹107.71.
GuruFocus considers Sharma East India Hospitals & Medical Research to be Modestly Undervalued.
Key valuation signals for BOM:524548:
3-Year ROIIC %: -4.09
GF Value™: ₹107.71 vs. price of ₹94.58 (12.2% below fair value)
No single metric tells the full story. See the BOM:524548 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sharma East India Hospitals & Medical Research Ltd is engaged in service activities related to the medical and healthcare services and real estate services. It provides healthcare services through the multi-specialty hospital in the name of Jaipur Hospital in Rajasthan. It provides services like joint replacement surgery, arthroscopy, cardiothoracic and vascular surgery, interventional cardiology, such as angiography and angioplasty, neurosurgery, and others.
73GF Score
Get the complete analysis for BOM:524548
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524548 has been successfully added to your 
